Chernett Jorey Increases Stake in Oncology Institute, Inc. to 10.2%

Jorey Chernett, through an amendment to Schedule 13G, has increased their beneficial ownership in Oncology Institute, Inc. The filing indicates that as of March 13, 2026, Chernett beneficially owned 10,115,944 shares of common stock, representing 10.23% of the outstanding shares. This ownership stake is based on 98,839,144 shares outstanding as of March 5, 2026, as reported in the company's Annual Report on Form 10-K filed on March 12, 2026. The filing also includes a certification that the securities were not acquired or held for the purpose of influencing the control of the issuer. The amendment number is 1, and the filing date is March 16, 2026.